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Issue,s and Findings 
Discussed in this study: An as-
sessment of the effectiveness of 
drug testing as a means of predict-
ing that a released arrestee will 
commit an additional offense or 
fail to appear in court during the 
pretrial period. Researchers ana-
lyzed data from Washington, D.C., 
Manhattan, New York, Dade 
County, Florida, Prince George's 
County, Maryland, Maricopa 
County, Arizona, and Milwaukee 
County, Wisconsin, for how urine 
test results and other factors (espe-
ially criminal records and commu-
nity ties) might have a bearing on 
postrelease misconduct (arrests 
and failure to appear). 
Key issues: Judges can detain or 
set special release conditions for 
defendants who are at high risk of 
pretrial misconduct. As one way to 
distinguish between those who will 
stay crime-free and appear for trial 
and those who will not, some juris-
dictions test arrestees for recent 
drug use. Because drug testing is 
expensive, it is valuable for this 
purpose only if it can improve pre-
dictions based on other, more 
readily available data, such as a 
defendant's criminal history and 
community ties. 
Findings: Overall, researchers 
found some evidence that drug 
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When considering a defendant for pre-
trial release, a judge must decide 
whether there is a significant probability 
that releasing the person before the trial 
will pose a danger to the public. Testing 
for drugs during pretrial processing may 
help a judge to decide whether to order 
supervised release, continued drug test-
ing, drug treatment, or detention until 
trial. Positive results from urinalysis may 
be one way to identify defendants who 
are at high risk of pretrial misconduct 
(i.e., an arrest, or failure to appear for 
trial). 
Drug testing is expensive, however. To 
be worthwhile, it must be able to im-
prove predictive accuracy beyond that 
offered by other, often readily available 
data (e.g., criminal history, ties to the 
community) in determining who will ei-
ther fail to show for trial or be rearrested 
following pretrial release. Because previ-
ous examinations of this issue had con-
flicting results, the National Institute of 
Justice (NIJ) sponsored a study to ana-
lyze data previously gathered from six 
different sites around the United States. 
This Research in Brief summarizes the 
study methods and key findings and offers 
an analysis of the data. 
Study methods 
The data used in this study were records of 
pretrial misconduct of arrestees who were 
booked into jail at six sites: Washington, 
D.C. (using three settings), Prince George's 
County, Maryland, Milwaukee County, 
Wisconsin, Maricopa County, Arizona, 
Manhattan, New York, and Dade County, 
Florida (see exhibit 1). 
The Washington, D.C., adult pretrial re-
lease program was the prototype for pro-
grams designed for juvenile arrestees in 
the District of Columbia and for defen-
dants in Prince George's County, Milwau-
kee County, and Maricopa County. For 
these programs, the courts received urine 
test results1 and randomly assigned several 
releasees to experimental postrelease su-
pervision programs. Researchers also used 
data in Washington, D.C., collected after 
the experimental phase of the project. 
Testing methods. The researchers used 
three tests of statistical significance-two 
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drug tests could not predict any type 
of behavior and others predicted ei-
ther rearrest or failure to appear but 
seldom both. 
e Predicting rearrest. A positive test 
for opiates helped predict rearrest. A 
positive test for cocaine helped pre-
dict misconduct in some sites, but 
the effect was not statistically signifi-
cant in a combined test across all 
sites. Positive tests for other drugs 
showed no consistent predictive 
power. 
e Predicting failure to appear. A 
positive test for cocaine helped pre-
dict failure to appear. Other positive 
test results showed no consistent 
predictive power. 
This study speculated that a key 
problem with urine test results was 
that they cannot distinguish between 
heavy and moderate drug users. This 
distinction is important because 
criminal behavior generally increases 
with heavy drug use. Without some 
measure of heavy use, the high risks 
among the roughly 60 percent of 
arrestees who test positive for an il-
licit substance appear indistinguish-
able from low risks for purposes of 
predicting their behavior if released. 
While this study did not explore the 
use of pretrial drug testing to identify 
arrestees in need of treatment and to 
see that they receive that treatment 
under judicial authority, the research-
ers cited this as one justification for 
such testing. 
Target audience: Local judges, 
prosecutors, policymakers, and pre-
trial release program administrators. 
Exhibit 1: Summary of Six Sites, Their Programs, and Their Dataa 
Site Subjects Dates Special Drugs Number of 
Conditions Tested Cases 
District of Adults, June 1984 to Experiment: cocaine 5,689 
Columbia except those Jan. 1985 periodic heroin 
D.C. Adults, arrested for testing; PCP 
1984 Federal and treatment amphetamines 
minor crimes methadone 
D.C. Juveniles Juveniles Oct. 1986 to Experiment: cocaine 2,137 
processed Jan. 1988 weekly heroin 
through testing; marijuana 




D. C. Adults, Adult 1989 to drug testing cocaine 1,538 
1989-1990 arrestees 1990 heroin 
interviewed PCP 
by NIJ Drug Use other drugs 
Forecasting methadone 
Program 
Prince Adults booked July 1988 to Experiment: cocaine 1,072 
George's Feb. 1989 drug testing heroin 
County, marijuana 
Maryland PCP 
Milwaukee Adults booked Feb. 1989 to Experiment: cocaine 830 
County, for felonies, Dec. 1989 drug testing heroin 
Wisconsin serious mis- amphetamines 
demeanors, and benzodiazepines 
outstanding 
warrants 
Maricopa Adults booked Beginning of Experiment: cocaine 186 
County, for felonies summer 1988 drug testing amphetamines 
Arizona other drugs 
Manhattan, Adults booked April to None cocaine 1,893 
New York for felonies Oct. 1984 heroin 
for nondrug PCP 
offenses methadone 
Dade County, Adults booked June to July None cocaine 1,294 
Florida for felonies 1987 marijuana 
excluding some 
senous crimes 
a Six diverse sites tested arrestees for recent use of several illicit substances. Sample sizes are the 
number of observations that entered the analys is, not the total collected. Washington, D.C., pro-
vided three different data sets, corresponding to three different settings. To avoid confusion, the 
first Washington setting is called "D.C. adults, 1984, " denoting that the data pertain to adult 
arrestees in 1984. The second Washington setting is called "D.C. juveniles" because the data 
pertain to juvenile arrestees who were processed through lockups between October 1986 and 
January 1988. The thi rd Wash ington setting is called "D.C. adults, 1989-1990" to indicate that 
the data pertain to adults who were arrested in 1989 and 1990 . 
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across all six sites. 
e The first test used a likelihood ratio 
test to determine if arrestees who 
tested positive for recent drug use had 
misconduct rates that differed from 
arrestees who tested negative. This test 
did not determine if rates were higher 
or lower, only if they were different. 
e The second used t-scores to calcu-
late if those who tested positive for 
each individual drug (e.g., cocaine, 
heroin, PCP) had higher misconduct 
rates than defendants who tested 
negative. 
e Finally, a meta-analysis combined 
results from across the six sites to de-
termine if defendants who tested posi-
tive for a particular drug engaged in 
pretrial misconduct more frequently 
than those who tested negative for that 
)ug. 
In these tests, the researchers also 
took into account criminal history, ties 
to the community, participation in spe-
cial supervision programs, and the 
length of time at risk (i.e., the amount 
of time between release and trial). 
Drug testing results as 
predictors 
The data showed that except for heroin 
use, pretrial drug testing did not ap-
pear to help predict rearrests and that 
except for cocaine use, testing did not 
help identify those who would fail to 
appear for trial. Even when individuals 
tested positive for more than one drug, 
testing did not improve the accuracy of 
predicting rearrests. 
Heroin. Heroin use, as determined by 
urinalysis, appeared to be a predictor 
~rearrest. In Manhattan, Prince 
\'--G-eorge's County, and Washington, 
D.C. (for both 1984 and 1989-90), 
positive tests for opiates were substan-
tively large in predicting rearrests 
after pretrial release. Across the six 
sites, results were statistically signifi-
cant (see exhibit 2). 
Cocaine. Positive tests for cocaine 
were less conclusive. Although at 
some sites cocaine-positive results 
predicted rearrest, they were not sta-
tistically significant across the six 
sites. In Washington, D.C., between 
1989 and 1990, cocaine-positive re-
sults among adults seemed to indicate 
that they could predict rearrest. How-
ever, among adults tested in 1984 and 
juveniles tested between 1986 and 
1988, positive cocaine tests did not 
predict rearrest. 
In Dade County, those who tested 
positive for cocaine were more likely 
to be rearrested than defendants who 
tested negative. But the results were 
not conclusive because they were 
barely statistically significant, and 
other ways of examining the data re-
sulted in different conclusions.2 
Positive cocaine results were not sta-
tistically significant in any of the other 
Exhibit 2: Predicted Probability of Rearrest Within 90 Days: Those Who 
Tested Positive for Recent Heroin Use 
.. 
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four sites. On balance, positive co-
caine tests did not consistently sup-
port the assertion that it was a 
predictor of rearrests once other fac-
tors had been taken into account. 
However, when taking other factors 
into account, positive tests for cocaine 
did predict failure to appear in court. 
Statistically significant results were 
found in Prince George's County, 
Maricopa County, and Washington, 
D.C., for adults during 1989-90 (no 
data were available for juveniles). 
When analyzing data across all six 
sites, results were both substantively 
large and statistically significant 
(see exhibit 3). 
Other drugs. Testing for marijuana, 
PCP, amphetamines, and other drugs 
did not appear to be particularly effec-
tive in predicting rearrest or failure to 
appear. Two sites were exceptions: 
Those with positive tests for amphet-
amines in Maricopa County and for 
PCP in 1984 in Washington, D.C., 
were more likely to fail to appear for 
their court dates. Inexplicably, PCP 
users in 1989-90 in D.C. were more 
likely to show up in court than those 
who tested negative for this drug. 
Exhibit 3: Predicted Probability of Failure to Appear: Those Who Tested 
Positive for Recent Cocaine Use 
0.40 ,----------------------., 
Positive 
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Other predictors of pretrial 
misconduct 
Rearrest. The study found that vari-
ables other than (or in addition to) 
drug test results were correlated with 
pretrial misconduct. A criminal history 
seemed to be the best predictor of re-
arrest; that is, there was a high corre-
lation between the number of previous 
arrests (or convictions when arrests 
were unknown) and rearrest during 
pretrial release. Other indexes of a 
criminal record, such as the number of 
previous probation/parole revocations 
and incarcerations, had varying pre-
dictive power at different sites. 
The seriousness of the initial arrest 
charge was found to have no effect on 
the probability of rearrest. Marital sta-
tus and length of time living in the 
community did not seem to play strong 
roles in predicting pretrial misconduct. 
Failure to appear. On the other hand, ( 
when data were available, employment 
and school attendance were useful in-
dexes in predicting both rearrest and 
failure to appear. 
Another finding was that the more se-
rious the initial arrest charge, the 
greater the likelihood that the defen-
dant would appear at court. The re-
searchers found this difficult to 
explain since defendants charged with 
serious crimes should have stronger 
incentives to fail to show up at court 
compared with those charged with less 
senous cnmes. 
First-time arrestees 
In this study, the number of prior ar-
rests was found to be the best predic-
tor of rearrests. So the researchers 
asked, "Is a drug test useful when pre-
dicting misconduct among those who (i 
have no recorded criminal history?" 
I Research in Brief ••• 
1
No effects were found at three (Dade 
County, Washington, D.C., juveniles, 
and Manhattan) of the five sites where 
sample sizes were sufficiently large to 
support an analysis of first-time 
arrestees. First-time arrestees in 1984 
in Washington, D.C., who tested posi-
tive for cocaine or heroin were less 
likely to be rearrested than first-time 
arrestees who tested negative for any 
drugs. However, first-time arrestees in 
1989-90 in D.C. who tested positive 
for cocaine were more likely to be re-
arrested. 
Overall, the significance of a positive 
correlation between a positive drug 
test and rearrest appeared slight. First-
time drug users who tested positive for 
any illicit substance were better risks 
for release than repeat offenders who 
did not test positive for recent drug 
use.3 
l 
Issues and implications 
Interpreting these findings is compli-
cated by the lack of a clear theoretical 
basis. Drug users are not a homoge-
neous group.4 Some are compulsive 
users while others use drugs occasion-
ally. Criminal behavior increases with 
heavy drug use, but infrequent users 
may comprise a considerable percent-
age of arrestees testing positive for 
drugs. 
The inability to differentiate serious 
users from infrequent users and to un-
derstand the role of drugs in the lives 
of arrestees may account for the incon-
sistency of these and other study find-
ings. For example, in this study 18 
percent of Washington, D.C., adult de-
fendants in 1984 and 73 percent of 
Dade County defendants in 1987 
tested positive for cocaine. Are they 
l}quivalent? In 1984, D.C. users were 
probably a select group using pow-
dered cocaine, while in 1987, Dade 
County users probably were using 
crack primarily. Yet they have been 
considered as the same category of co-
caine users when analyzing whether 
urine tests predicted pretrial miscon-
duct. 
Thus, one implication of these findings 
is that much of the ambiguity of drug-
testing results derives from the inabil-
ity of urinalysis to separate high-rate 
users from low-rate users, those who 
are addicted and who will commit 
crimes to maintain their drug needs 
from those who may buy drugs on a ca-
sual basis with money they earned le-
gitimately. Several ways may exist to 
make this distinction: 
e Use urine test results from two or 
more previous sequential arrests to 
establish that an arrestee is a problem 
user. This could only be done in areas 
that have established drug-testing pro-
grams, but reconstructing drug histo-
ries using a computer would be 
practical. Evidence from other studies 
supports the possibility that use of pre-
vious tests could help predict future 
pretrial misconduct. 5 
e Conduct many urine tests during 
the pretrial period to determine the 
level of drug use. Most programs gave 
the judge the option to continue testing 
during pretrial release supervision, 
and other researchers found that sites 
replicating the D.C. program tested 
defendants an average of 10 times be-
fore trial.6 Such prospective screens 
would be less expensive if they were 
limited to defendants who were identi-
fied by criteria for risk that involved 
more than a single positive urine test. 
e Use other tests for drugs, such as 
hair testing. Hair testing appears to be 
I •• 5 •• I 
a better determinant of long-term drug 
consumption. 
Future research might concentrate on 
determining the effectiveness 'of these 
approaches and on developing a better 
understanding of the role of drug use 
in offenders' lives. At present, in its 
current form, pretrial drug testing may 
best be used to identify those who 
need treatment for drug abuse. 
Notes 
l. Courts in Manhattan and Dade County 
did not receive drug test results. 
2. The t-score was 1.805, which is just sta-
tistically significant at p <0.05. See also 
Goldkamp, J., M. Gottfredson, and D. 
Weiland, "Pretrial Drug Testing and Ar-
rest Risk," The Journal of Criminal Law 
and Criminology, 81:3(1990) 585-652. 
3. See Smith, D., and C. Polsenberg, 
"Specifying the Relationship Between 
Arrestee Drug Test Results and Recidi-
vism," The Journal of Criminal Law and 
Criminology, 83:2(1992)364-77. They 
analyzed the 1989-90 data for District of 
Columbia adults and reported that a posi-
tive test for recent cocaine use was highly 
predictive of being rearrested, especially 
for first-time arrestees. However, they also 
reported that these first-time arrestees 
with positive cocaine tests did not have 
higher rearrest rates than those who had 
negative drug tests but prior criminal 
records. (The researchers are indebted to 
Jan Chaiken for making this observation.) 
4. Chaiken, M., and B. Johnson, Charac-
teristics of Different Types of Drug-Involved 
Offenders, Washington, D.C.: U.S. Depart-
ment of Justice, National Institute of Jus-
tice, 1988. 
5. See Toborg, M., J. Bellassai, A. Y ezer, 
and R. Trost, Assessment of Pretrial Urine 
Testing in the District of Columbia, Wash-
ington, D.C.: U.S. Department of Justice, 
National Institute of Justice, 1989; Visher, 
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C., "Using Drug Testing to Identify High-
Risk Defendants on Release: A Study in 
the District of Columbia," Journal of 
Criminal Justice, 18(1990)321-32. They 
reported that defendants who failed mul-
tiple drug tests during pretrial release 
were most likely to engage in pretrial mis-
conduct. This also points to the possibility 
that retrospective drug tests may be 
equally useful. 
6. Bureau of Justice Assistance, "Estimat-
ing the Cost of Drug Testing for A Pretrial 
Services Program," Washington, D.C., 
U.S. Department of Justice, Bureau of Jus-
tice Assistance, 1989. 
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available from the National Crimi-
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tel. 800-851-3420, or e-mail 
askncjrs@ncjrs.aspensys.com. 
Ask for NCJ 150551. 
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